Peer-influenced content. Sources you trust. No registration required. This is HCN.
Annals of Internal Medicine
Explore the study’s analysis, which also uncovers potential cardiovascular benefits associated with SGLT2i initiation among patients with gout and type 2 diabetes.
Cardiology August 3rd 2023
ActiveBeat
With the resurgence of gout in individuals over 30, it’s important to recognize its primary triggers and symptoms for early diagnosis and management, ensuring this treatable form of arthritis doesn’t lead to long-term damage in patients.
Family Medicine/General Practice July 27th 2023
In contradistinction to recent reports that showed increased risk of death and no clinical benefit with escalation of allopurinol for progressive CKD, this 5-year population-based review found no increased mortality risk in escalating allopurinol dose and achieving target serum urate levels.
Family Medicine/General Practice February 1st 2022